3 No-Brainer Dividend Stocks to Buy Right Now

Cardinal Health’s post-transformation momentum leaves it with 30 years of consecutive dividend increases, a forward yield of ~1%, a low payout ratio (~30.6%) and brokered earnings growth forecasts of ~19.3% for FY2026 and ~12.6% for FY2027, suggesting scope for materially higher dividend growth if management returns more cash. Chevron, facing low oil prices but beating recent production expectations, laid out a Nov. 12 plan to prioritize cash-flow growth through cost and capex cuts and expansion into power for AI data centers, while maintaining commitment to buybacks and dividend increases (forward yield ~4.5%, payout ratio ~95%; 25-year avg dividend growth ~7%/yr). Target offers a ~5% forward yield with a ~55% payout ratio, 54 years of consecutive raises and modest recent increases (1.8%), implying sustainable income with upside if a retail turnaround boosts earnings or triggers takeover interest.

Analysis

Market structure: The winners are specialty-focused healthcare distributors (Cardinal Health, CAH) and shareholder-friendly energy names (Chevron, CVX) that can convert cash-flow into buybacks/dividends; discount retailers (Target, TGT) benefit if comps recover. Losers are lower-margin broad distributors and energy firms without disciplined capex; specialty/managed-services exposure compresses volumes for commodity-focused peers. Natural gas demand from AI datacenters implied by Chevron’s plan would tighten US gas fundamentals if adoption scales, supporting energy equities but adding commodity-price tail risk.

Risk assessment: Tail risks include regulatory/legal shocks to distributors (opioid/contract litigation), a steep oil-price collapse (Brent < $60 for multiple quarters) that erodes CVX free cash flow, or a retail consumer pullback that pressures TGT comps. Immediate effects (days) will be earnings/guide reactions; short-term (weeks–months) hinge on buyback/dividend announcements; long-term (12–36 months) depends on successful specialty penetration (CAH) and Chevron’s power contracts delivering positive margin. Hidden dependencies: CAH’s dividend optionality depends on realized specialty margins and payer dynamics; CVX’s payout relies on successful capex cuts and gas-price stability.

Trade implications: Favor selective long exposure to CAH for growth + dividend optionality and to CVX for yield if you hedge commodity risk; use covered-call and cash-secured-put structures to harvest premium. Relative-value: long CAH vs short AmerisourceBergen (ABC) isolates the pivot-to-specialty trade. Monitor catalysts—next 2–4 quarter earnings, Chevron investor-day follow-ups, and any PE movement around TGT for takeover premium.

Contrarian angles: The market underestimates CAH’s capacity to materially raise dividends (payout ~30%, FY26 est EPS growth ~19%), so dividend-growth rerating is possible if growth persists. Conversely CVX’s high payout ratio (~95%) is priced for fragility; management’s cost cuts could be understated by consensus, leaving upside if FCF improves. Unintended consequences include CVX locking into long-term power contracts that cap margins or CAH raising dividends at the expense of strategic reinvestment—watch FCF allocation closely.

Key Decisions for Investors

• Establish a 2–3% long position in Cardinal Health (CAH) within 30 days, size up on any pullback of 8–12%; hold 12–24 months and trim if CAH misses FY26 EPS by >10% or if payout ratio rises above 45%.
• Initiate a 3–4% core position in Chevron (CVX) but structure as buy-and-sell covered calls (sell 6–10 week calls to harvest yield) or buy 12–18 month LEAP calls (5–10% OTM) financed by selling short-dated calls; reduce exposure if Brent < $65 for two consecutive months or company guidance cuts FCF by >10%.
• Deploy a 1–2% options-based TGT trade: sell 3–6 month cash-secured puts ~5% below current price to collect premium and acquire shares if exercised; hold 12–24 months and increase only if takeover bid rumors intensify or comparable-store-sales accelerate >200 bps YoY.
• Open a 1–2% pair trade long CAH / short AmerisourceBergen (ABC) to isolate the specialty-distribution rerating, close within 6–12 months or when the relative spread tightens by 50%; cap total energy exposure at ≤6% of portfolio and buy 6-month 10% OTM puts on CVX if position exceeds 3%.